Literature DB >> 7247557

Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure.

S C Immerman, R M Vanecko, W A Fry, L R Head, T W Shields.   

Abstract

Ninety-nine patients with Stage I or II lung carcinoma that was other than the small cell type and who survived for more than 30 days after a "curative" resection were followed for five years or until death if it occurred prior to the five-year anniversary. Recurrent disease developed in 44 patients. Clinical data and data from postmortem examination were reviewed in these 44 patients in an attempt to classify each recurrence as either initially local or distinct metastatic disease. The site of the first documented recurrence was local in 18 patients and distance metastases in 26. When the patients with recurrence were separated into TNM categories, it was apparent that in those patients without lymph nodes metastases demonstrated in the resected specimen (N0), the initial recurrence tended to be a distant metastases, whereas in those with such involvement (N1), the initial occurrence was more often local. In light of these data, selection of appropriate initial adjuvant therapeutic modalities may be different for each type of patient.

Entities:  

Mesh:

Year:  1981        PMID: 7247557     DOI: 10.1016/s0003-4975(10)61368-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

Review 1.  Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.

Authors:  Tara L Lin; Julie R Brahmer
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

Review 2.  Adjuvant therapy for resected non-small-cell lung cancer: past, present, and future.

Authors:  Rosalyn A Juergens; Julie R Brahmer
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.075

3.  Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based study.

Authors:  Zhong-Zhe Lin; Wen-Yi Shau; Yu-Yun Shao; Yen-Yun Yang; Raymond Nien-Chen Kuo; James Chih-Hsin Yang; Mei-Shu Lai
Journal:  Oncologist       Date:  2012-07-23

4.  Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.

Authors: 
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

5.  Staging and management of lung cancer: sleeve resection.

Authors:  J Deslauriers; R J Mehran; C Guimont; J Brisson
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

Review 6.  Lung cancer--current concepts and controversies.

Authors:  S B Pett; J A Wernly; B F Akl
Journal:  West J Med       Date:  1986-07

7.  Recurrence at the bronchial stump after resection of lung cancer.

Authors:  H Miura; C Konaka; H Kato; N Kawate; O Taira
Journal:  Ann Surg       Date:  1994-03       Impact factor: 12.969

8.  Epidemiology of lung cancer prognosis: quantity and quality of life.

Authors:  Ping Yang
Journal:  Methods Mol Biol       Date:  2009

9.  Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer.

Authors:  D Grant; D Edwards; P Goldstraw
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

10.  Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer.

Authors:  Jue Wang; Yong Fang Kuo; Jean Freeman; Avi B Markowitz; James S Goodwin
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.